Measurements of the amount of ATP released by bladder distention and VNUT expression in the bladder. by Takafumi Kabuto (14797727)

Subjects:

NS co-suppresses Ox-LDL-induced apoptosis in RAW264.7 cells. by Yihua Wang (491766)

Subjects:

Measurement of micturition behavior in the rats. by Takafumi Kabuto (14797727)

Subjects:

NS delays the formation of atherosclerotic plaques in ApoE^-/- mouse models. by Yihua Wang (491766)

Subjects:

NS attenuates ox-LDL-induced foam cell formation. by Yihua Wang (491766)

Subjects:

NS affects the PI3K/AKT/mTOR pathway in RAW264.7 cells. by Yihua Wang (491766)

Subjects:

NS enhances autophagy inhibits atherosclerosis in RAW264.7 cells. by Yihua Wang (491766)

Subjects:

NS suppresses inflammation induced by Ox-LDL in RAW264.7 cells. by Yihua Wang (491766)

Subjects:

NS affects lipid transport in ApoE^-/-mouse models. by Yihua Wang (491766)

Subjects:

NS restores macrophage autophagy and alleviates the progression of atherosclerosis by inhibiting the PI3K/Akt/mTOR pathway. by Yihua Wang (491766)

Subjects:

Fourier-transform infrared spectroscopy (FTIR) spectra of GA (black), GO (blue), and GO–GA NPs (red). by Huda H. Elbehery (22492996)

Subjects:

Toxicity of GO and GO-GA NPs on <i>C. maculatus</i> adults after 24h exposure. by Huda H. Elbehery (22492996)

Subjects:

Post-effect of GO and GO-GA NPs on progeny production of <i>Callosobruchus maculatus.</i> by Huda H. Elbehery (22492996)

Subjects:

Transmission electron micrographs of GA NPs (a) and GO-GA NPs (b). by Huda H. Elbehery (22492996)

Subjects:

Particle size distribution, PDI, and zeta potential of GO-GA NPs. by Huda H. Elbehery (22492996)

Subjects:

PT₅₀ values of GO and GO-GA NPs against <i>Callosobruchus maculatus.</i> by Huda H. Elbehery (22492996)

Subjects:

Volatile constituents of Garlic essential oil identified by GC-MS. by Huda H. Elbehery (22492996)

Subjects:

Liver weights were normalized by the mouse body weight to derive the %liver weight. by Bryan S. Margulies (21492667)

Subjects:

Inhibitor versus the normalized dose response curves. by Bryan S. Margulies (21492667)

Subjects:

Characteristics of census tracts that are projected to have high (groups: 250-399 and 400+) and low (groups: 50-99 and 100-249) MHC utilization for COVID-19 vaccination before Marc... by Fatih Gezer (21485468)